Research at HCG

Discovery Science, Built into Cancer Care

Research at HCG spans the full translational arc - from the molecular diagnostics that guide everyday cancer care to frontier discovery science. The platforms below are operational today and shared across clinical and research programmes.

Incubated by HCG Hospitals
ARTS
Adarsh Advanced Research & Technology Sciences

HCG's clinical and diagnostic foundations feed its dedicated translational research centre - where cancer and longevity science advance from discovery to patient impact.

Explore ARTS →

contact@aartslab.com

Platform

Genomics

Clinical sequencing runs on Illumina NovaSeq X Plus platforms, delivering whole-genome, whole-exome, RNA, and liquid-biopsy profiling. Comprehensive tumour and germline testing informs precision-oncology decisions across HCG's 25+ centre network.

Platform

Proteomics

Deep clinical proteomics is powered by Orbitrap Astral mass spectrometry - one of fewer than ten such instruments in Asia. It enables tissue and plasma proteome mapping for biomarker discovery, liquid-biopsy development, and multi-omic integration with genomic data.

Diagnostics & Therapies

Triesta, CAR-T & BMT

Triesta, HCG's central reference laboratory, delivers molecular diagnostics, immunohistochemistry, flow cytometry, and companion testing at national scale. Advanced therapeutic programmes include CAR-T cell therapy and bone-marrow transplantation, backed by a biorepository of 350,000+ annotated biospecimens.

AI & Computational

AI Pathology & Spatial Biology

In a first-of-its-kind South Asian collaboration with Accenture, HCG applies generative AI and deep learning to multi-omic patient data - spanning digital pathology and spatial biology - to strengthen early detection, surface molecular signatures, and accelerate precision-oncology treatment.